GlaxoSmithKline Pharmaceuticals has announced a key leadership transition. Mr. Juby Chandy, the current Whole-Time Director & CFO, will step down effective March 11, 2026, to take on a new role within the GSK Group. He will be succeeded by Mr. Ronojit Biswas, who has been appointed as the new Whole-Time Director & CFO for a three-year term starting April 1, 2026. The company expressed sincere appreciation for Mr. Chandy’s contributions.
Board Approves Key Executive Changes
The Board of Directors of GlaxoSmithKline Pharmaceuticals Limited, following its meeting held on 2nd March 2026, formally approved significant changes to its executive leadership team concerning the Finance function.
Appointment of New CFO
Mr. Ronojit Biswas (DIN 07684843) has been appointed as the new Whole-Time Director & Chief Financial Officer (CFO) of the Company. This appointment is effective from 1st April 2026, for a term spanning three years. The announcement confirmed that Mr. Biswas is not related to any existing Directors and is not debarred by any regulatory authority.
Profile of Ronojit Biswas
Mr. Biswas is a seasoned finance leader boasting over 25 years of experience with GSK across various international markets, including leadership roles in India, Vietnam, Singapore, Brazil, and the UK. He began his career with GSK in India in 1999. Most recently, he served as the Senior Finance Director for Global Product Strategy, based in Singapore. He holds a Post Graduate Program in Management (Finance) from the Management Development Institute, Gurgaon.
Transition of Current CFO
Mr. Juby Chandy, the current Whole-Time Director and CFO, will be stepping down from these roles effective March 11, 2026. Mr. Chandy is transitioning into a new role within the broader GSK Group, specifically noted to lead APAC Finance. The Board recorded its sincere appreciation for Mr. Chandy’s central role in strengthening the financial position and governance of the Company.
Meeting Conclusion
The Board Meeting commenced at 11.00 am and concluded at 12.00 noon on the date of the announcement.
Source: BSE
